Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men

January 1, 2007 Human Health and Nutrition Data 0 Comments

Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men

Year: 2007
Authors: Paschos, G.K., Zampelas, A., Panagiotakos, D.B., Katsiougiannis, S., Griffin, B.A., Votteas, V., Skopouli, F.N.
Publication Name: Eur. J. Nutr.
Publication Details: Volume 46; Pages 315–320.


Background Dietary alpha-linolenic acid (ALA) has been associated with reduced risk of development of atherosclerosis. Adiponectin is a hormone specifically secreted by adipocytes and considered to have anti-atherogenic properties.                                                                                                                      Aim of the study: We examined the effect of increased dietary intake of ALA on plasma concentration of adiponectin.
Methods: Thirty-five nondiabetic, dyslipidemic men, 38– 71 years old, were randomly allocated to take either 15 ml of flaxseed oil rich in ALA (8.1 g/day; n = 18), or 15 ml of safflower oil per day, containing the equivalent n-6 fatty acid (11.2 g/day linoleic acid, LA; n = 17) (control group). The intervention period lasted for 12 weeks.                                                                                                                             Results: Plasma levels of adiponectin did not change after the increase in dietary intake of ALA in the flaxseed oil supplementation group, compared to the control group. No changes in body mass index, serum lipid concentrations, LDL density, or plasma TNF-a were found in the flaxseed oil versus the control group.
Conclusions Dietary ALA has no effect on plasma adiponectin concentration in dyslipidemic men. Author's Abstract.

Back to Databases

Affiliated Organizations

Flax Focus Newsletter

Stay up-to-date with important flax news and announcements with our FLAX FOCUS newsletter.